Vivos Therapeutics (VVOS) Current Deferred Revenue (2019 - 2026)
Vivos Therapeutics (VVOS) reported Current Deferred Revenue of $583,000 for Q2 2026, up 21.5% from $480,000 a year earlier and up 17.8% from the prior quarter.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Current Deferred Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025, Vivos Therapeutics posted Current Deferred Revenue of $479,000, down 46.5% from FY2024.
- Current Deferred Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -30.4% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $896,000 in FY2024 (-58.1%), $2.14 million in FY2023 (-26.9%), $2.93 million in FY2022 (+22.0%) and $2.4 million in FY2021 (-18.3%).
- The Q2 2026 figure ranks as the highest quarterly Current Deferred Revenue since Q4 2024.
- Year over year, Current Deferred Revenue gained in 1 of the last eight quarters, with an average decline of 43.7%.
- The high point for year-over-year Current Deferred Revenue in five years was Q1 2023 (growth of 48.2%); the low point was Q1 2025 (a decline of 76.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $495,000 (Q1 2026), $479,000 (Q4 2025) and $537,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 254.70 Bn | 233.73 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 179.59 Bn | 150.02 Bn | 7.27 Bn |
| 3 | Danaher | 158.34 Bn | 142.15 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 155.01 Bn | 134.44 Bn | 1.96 Bn |
| 5 | Medtronic | 120.80 Bn | 86.05 Bn | 6.34 Bn |
| 6 | Stryker | 116.57 Bn | 102.68 Bn | 4.50 Bn |
| 7 | Boston Scientific | 66.65 Bn | 61.42 Bn | 3.85 Bn |
| 8 | Becton Dickinson | 53.03 Bn | 50.18 Bn | 2.32 Bn |
| 9 | Edwards Lifesciences | 50.70 Bn | 34.71 Bn | 1.35 Bn |
| 10 | Vivos Therapeutics | 2.36 Mn | -6.67 Mn | 2.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 583,000.00 |
| Mar 31, 2026 | 495,000.00 |
| Dec 31, 2025 | 479,000.00 |
| Sep 30, 2025 | 537,000.00 |
| Jun 30, 2025 | 480,000.00 |
| Mar 31, 2025 | 572,000.00 |
| Dec 31, 2024 | 896,000.00 |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Jun 30, 2022 | 2.08 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 2.40 Mn |
| Sep 30, 2021 | 3.70 Mn |
API Access
Vivos Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VVOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VVOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VVOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();